Barrett's Esophagus Without Dysplasia Clinical Trial
Official title:
Cell Marker Predictors in Barrett's Esophagus
Verified date | February 2024 |
Source | The Guthrie Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Status | Active, not recruiting |
Enrollment | 25 |
Est. completion date | December 1, 2025 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - History of Barrett's esophagus; scheduled for routine upper endoscopy Exclusion Criteria: - Under 18 years of age - Unable to consent on own behalf |
Country | Name | City | State |
---|---|---|---|
United States | The Guthrie Clinic | Sayre | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
The Guthrie Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cell Markers | Identify genes involved in Barrett's Esophagus | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Not yet recruiting |
NCT05745857 -
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
|
Phase 2 | |
Recruiting |
NCT04295811 -
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
|
N/A | |
Completed |
NCT03814824 -
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
|
N/A | |
Enrolling by invitation |
NCT04561791 -
Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
|
N/A | |
Completed |
NCT04293458 -
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
|
N/A | |
Completed |
NCT06381583 -
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
|
||
Recruiting |
NCT05965999 -
Lucid Registry Study
|